Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

244.88
+3.881.61%
Pre-market: 246.311.43+0.58%07:15 EDT
Volume:10.13M
Turnover:2.49B
Market Cap:589.99B
PE:28.36
High:248.19
Open:241.27
Low:240.89
Close:241.00
52wk High:251.71
52wk Low:151.01
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.90
T/O Rate:0.42%
Dividend:5.20
Dividend Rate:2.12%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:26.42%
ROA:8.42%
PB:7.27
PE(LYR):22.19

Loading ...

Guggenheim Adjusts Price Target on Johnson & Johnson to $270 From $266, Maintains Buy Rating

MT Newswires Live
·
1 hour ago

U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex

Reuters
·
4 hours ago

The Dow Hits Record High, Caterpillar Surges Over 5%

Tiger Newspress
·
Yesterday

Johnson & Johnson's Study of Carotid IVL Platform Treats First Patient

MT Newswires Live
·
Yesterday

J&J: Begins Enrollment in Pivotal Studies Evaluating First-of-its-kind Carotid Ivl Platform

THOMSON REUTERS
·
Yesterday

Johnson & Johnson Advances Cardiac Ablation Technology in Europe

Reuters
·
Yesterday

Johnson & Johnson Launches Dual Energy Thermocool Smarttouch SF Cardiac Ablation Platform in Europe

Reuters
·
Yesterday

Picard Medical Names Chairman Richard Fang Interim CEO After Schnegelsberg Steps Down

Reuters
·
Jun 24

Perrigo Co. PLC Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jun 24

Movement Alert|Johnson & Johnson Rises 3.03% in Regular Trading, Talcum Powder Lawsuit Damages Halved by Court Ruling

Market Focus
·
Jun 24

FTC Release: FTC Files Amicus Brief to Protect Consumers from Pharmaceutical Monopolies

Dow Jones
·
Jun 24

Alpha Cognition elects Robert Wills as board chairman

Reuters
·
Jun 23

Insmed names Samuele Butera SVP, GM of global respiratory unit

Reuters
·
Jun 23

Definium's LSD-based depression pill delivers strong late-stage results, shares surge

Reuters
·
Jun 22

Johnson & Johnson (JNJ) Stock Could Be 7.3% Undervalued Based On Its Pharma And MedTech Focus

Simply Wall St.
·
Jun 21

Income Investing: 50 Years of Dividend Hikes: These Stocks Did It -- Barron's

Dow Jones
·
Jun 20

J&J says MEMBRANE trial shows TRUFILL n-BCA MMA embolization cuts chronic subdural hematoma recurrence risk 47%

Reuters
·
Jun 19

AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 19

Johnson & Johnson on Pace for Largest Percent Decrease Since May 2025 -- Data Talk

Dow Jones
·
Jun 18

BUZZ-Legend Biotech slides on $226 mln share sale

Reuters
·
Jun 18